The Significance of Blood Levels of IgM, IgA, IgG and IgG Subclasses in Sudanese Visceral Leishmaniasis Patients

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1994 Feb 1

PMID 8306504

Citations 17

Authors

A M Elassad

S A Younis

M Siddig

J Grayson

E Petersen

H W Ghalib

Affiliations

Soon will be listed here.

Abstract

We developed an ELISA test using leishmania antigenic extracts to detect antigen-specific antibody responses, including subclass and isotype analysis, in visceral leishmaniasis (VL) patients from the Sudan. A total of 92 parasitologically proven patients were compared with cutaneous leishmaniasis, schistosomiasis, malaria, onchocerciasis and tuberculosis patients, as well as with healthy endemic and non-endemic controls. Some VL patients were examined before and after chemotherapy. VL patients showed significantly higher IgG responses compared with all other groups (93.4% sensitivity, 93.7% specificity), and higher (but not significantly) IgM responses. All groups showed low IgA levels. All IgG subclasses, IgG1, 2, 3, and 4, showed higher levels in patients than all other groups, with IgG1 and IgG3 levels being significantly reduced following treatment. The rank order for specificity and sensitivity for IgG subclasses was IgG3 > IgG1 > IgG2 > IgG4.

Citing Articles

Antileishmanial Drug Discovery and Development: Time to Reset the Model?.

Olias-Molero A, de la Fuente C, Cuquerella M, Torrado J, Alunda J Microorganisms. 2021; 9(12).

PMID: 34946102 PMC: 8703564. DOI: 10.3390/microorganisms9122500.

Infection of dogs by Leishmania infantum elicits a general response of IgG subclasses.

Olias-Molero A, Moreno I, Corral M, Jimenez-Anton M, Day M, Dominguez M Sci Rep. 2020; 10(1):18826.

PMID: 33139752 PMC: 7606601. DOI: 10.1038/s41598-020-75569-6.

Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection.

Hosein S, Rodriguez-Cortes A, Blake D, Allenspach K, Alberola J, Solano-Gallego L PLoS One. 2015; 10(10):e0140325.

PMID: 26465878 PMC: 4605763. DOI: 10.1371/journal.pone.0140325.

Preclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.

Lima L, Ramos P, Campos M, Vasconcelos Dos Santos T, Gomes C, Laurenti M Pathog Glob Health. 2014; 108(8):381-4.

PMID: 25491437 PMC: 4394671. DOI: 10.1179/2047773214Y.0000000166.

Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Kip A, Balasegaram M, Beijnen J, Schellens J, de Vries P, Dorlo T Antimicrob Agents Chemother. 2014; 59(1):1-14.

PMID: 25367913 PMC: 4291336. DOI: 10.1128/AAC.04298-14.

References

El Safi S, Evans D . A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. Trans R Soc Trop Med Hyg. 1989; 83(3):334-7. DOI: 10.1016/0035-9203(89)90493-8. View

Neogy A, Nandy A, Dastidar B, Chowdhury A . Antibody kinetics in kala-azar in response to treatment. Ann Trop Med Parasitol. 1987; 81(6):727-9. DOI: 10.1080/00034983.1987.11812177. View

Reed S, Shreffler W, Burns Jr J, Scott J, Orge M, Ghalib H . An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg. 1990; 43(6):632-9. DOI: 10.4269/ajtmh.1990.43.632. View

Heinzel F, Sadick M, Mutha S, Locksley R . Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci U S A. 1991; 88(16):7011-5. PMC: 52223. DOI: 10.1073/pnas.88.16.7011. View

Zijlstra E, Ali M, El-Hassan A, Satti M, Ghalib H, Sondorp E . Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings. Trans R Soc Trop Med Hyg. 1991; 85(3):365-9. DOI: 10.1016/0035-9203(91)90293-8. View

Dafaalla T, Ghalib H, Abdelmageed A, Williams J . The profile of IgG and IgG subclasses of onchocerciasis patients. Clin Exp Immunol. 1992; 88(2):258-63. PMC: 1554306. DOI: 10.1111/j.1365-2249.1992.tb03070.x. View

Ashford R, Seaman J, Schorscher J, Pratlong F . Epidemic visceral leishmaniasis in southern Sudan: identity and systematic position of the parasites from patients and vectors. Trans R Soc Trop Med Hyg. 1992; 86(4):379-80. DOI: 10.1016/0035-9203(92)90229-6. View

Falconer A, Carson R, Johnstone R, Bird P, Kehoe M, Calvert J . Distinct IgG1 and IgG3 subclass responses to two streptococcal protein antigens in man: analysis of antibodies to streptolysin O and M protein using standardized subclass-specific enzyme-linked immunosorbent assays. Immunology. 1993; 79(1):89-94. PMC: 1422057. View

Ghalib H, Piuvezam M, Skeiky Y, Siddig M, Hashim F, El-Hassan A . Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest. 1993; 92(1):324-9. PMC: 293600. DOI: 10.1172/JCI116570. View

10.

El-Hassan A, Hashim F, Ali M, Ghalib H, Zijlstra E . Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north. Trans R Soc Trop Med Hyg. 1993; 87(4):395-8. DOI: 10.1016/0035-9203(93)90010-n. View

11.

Mortimer G, Widdowson J . Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein. Clin Exp Immunol. 1979; 37(2):247-58. PMC: 1537815. View

12.

Siber G, Schur P, Aisenberg A, Weitzman S, Schiffman G . Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med. 1980; 303(4):178-82. DOI: 10.1056/NEJM198007243030402. View

13.

Poulter L . Mechanisms of immunity to leishmaniasis. I. Evidence for a changing basis of protection in self-limiting disease. Clin Exp Immunol. 1980; 39(1):14-26. PMC: 1537936. View

14.

Pearson R, Steigbigel R . Mechanism of lethal effect of human serum upon Leishmania donovani. J Immunol. 1980; 125(5):2195-201. View

15.

Richardson M, Turner A, Warnock D, Llewellyn P . Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis. J Immunol Methods. 1983; 56(2):201-7. DOI: 10.1016/0022-1759(83)90412-x. View

16.

Ho M, Leeuwenburg J, Mbugua G, Wamachi A, Voller A . An enzyme-linked immunosorbent assay (ELISA) for field diagnosis of visceral leishmaniasis. Am J Trop Med Hyg. 1983; 32(5):943-6. DOI: 10.4269/ajtmh.1983.32.943. View

17.

Sacks D, Scott P, Asofsky R, Sher F . Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J Immunol. 1984; 132(4):2072-7. View

18.

Galvao-Castro B, Sa Ferreira J, Marzochi K, Marzochi M, Coutinho S, Lambert P . Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis. Clin Exp Immunol. 1984; 56(1):58-66. PMC: 1535977. View

19.

Bird P, Lowe J, Stokes R, Bird A, LING N, Jefferis R . The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity. J Immunol Methods. 1984; 71(1):97-105. DOI: 10.1016/0022-1759(84)90209-6. View

20.

Hoover D, Berger M, Oppenheim M, Hockmeyer W, Meltzer M . Cytotoxicity of human serum for Leishmania donovani amastigotes: antibody facilitation of alternate complement pathway-mediated killing. Infect Immun. 1985; 47(1):247-52. PMC: 261503. DOI: 10.1128/iai.47.1.247-252.1985. View